Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Other Non-Current Liabilities: 2010-2020

Historic Other Non-Current Liabilities for Neurocrine Biosciences (NBIX) over the last 10 years, with Dec 2020 value amounting to $9.7 million.

  • Neurocrine Biosciences' Other Non-Current Liabilities rose 93.02% to $8.3 million in Q3 2021 from the same period last year, while for Sep 2021 it was $8.3 million, marking a year-over-year increase of 93.02%. This contributed to the annual value of $9.7 million for FY2020, which is 43.27% down from last year.
  • As of FY2020, Neurocrine Biosciences' Other Non-Current Liabilities stood at $9.7 million, which was down 43.27% from $17.1 million recorded in FY2019.
  • Over the past 5 years, Neurocrine Biosciences' Other Non-Current Liabilities peaked at $35.7 million during FY2018, and registered a low of $113,000 during FY2016.
  • Moreover, its 3-year median value for Other Non-Current Liabilities was $17.1 million (2019), whereas its average is $20.8 million.
  • Data for Neurocrine Biosciences' Other Non-Current Liabilities shows a maximum YoY crashed of 52.04% (in 2019) over the last 5 years.
  • Over the past 4 years, Neurocrine Biosciences' Other Non-Current Liabilities (Yearly) stood at $113,000 in 2016, then reached $35.7 million in 2018, then crashed by 52.04% to $17.1 million in 2019, then tumbled by 43.27% to $9.7 million in 2020.